The performance of companies tied to iconic drugs like Viagra presents a complex investment landscape . While the initial boom of copyright, fueled by Viagra's remarkable popularity, generated substantial returns, the patent expiration in key territories has introduced substantial volatility. Investors are now facing the consequences of lower-cost